Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV000565323 | SCV000661544 | likely benign | Hereditary cancer-predisposing syndrome | 2016-07-01 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Labcorp Genetics |
RCV000915112 | SCV001060307 | likely benign | Familial cancer of breast; Fanconi anemia complementation group J | 2025-01-19 | criteria provided, single submitter | clinical testing | |
Color Diagnostics, |
RCV000565323 | SCV001348314 | likely benign | Hereditary cancer-predisposing syndrome | 2018-10-25 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV001779009 | SCV002014854 | likely benign | not specified | 2021-10-10 | criteria provided, single submitter | clinical testing | |
Myriad Genetics, |
RCV004787905 | SCV005406985 | benign | Familial cancer of breast | 2024-09-05 | criteria provided, single submitter | clinical testing | This variant is considered benign. This variant is a silent/synonymous amino acid change and it is not expected to impact splicing. |